Article
No association between polymorphisms in the neprilysin promoter region and Swedish Alzheimer's disease patients.
Neuroscience letters - 6 Feb 2003
Lilius Lena, Forsell Charlotte, Axelman Karin, Winblad Bengt, Graff Caroline, Tjernberg Lars
Abstract excerpt
Amyloid beta-peptide (Abeta) deposition in brain is important in the development of Alzheimer's disease (AD). Neprilysin (NEP) appears to be the major Abeta degrading enzyme in vivo and reduced mRNA levels of NEP correlates with increased plaque density. We hypothesized that alterations in the NEP promoter region may alter NEP expression and thus be involved in the AD process. We investigated three putative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
